Teva Pharmaceuticals has a new game plan for raising awareness of tardive dyskinesia. More: Teva drafts NFL star Terrell Davis for tardive dyskinesia awareness drive Source: fierce
read moreThe company remains confident in the continued sales potential of Austedo after wrapping up government negotiations that will change the Medicare price for its top-seller in 2027. More: Teva CEO touts 'defining strength' of innovative drugs as its sales grow
read moreMadrigal’s Rezdiffra generated sales of $287 million in the third quarter for a 35% sequential jump from Q2. In just its fifth full quarter on the market, the world’s first treatment for metabolic dysfunction-associated steatohepatitis (MASH) is now annualizing at
read moreThe companies and federal officials are engaged in talks and the deals could come together this week, according to reports from Endpoints News and The Wall Street Journal. More: Lilly, Novo Nordisk in pricing, coverage talks with Trump administration on
read moreEven without accounting for the COVID-related declines that have punctuated Pfizer’s earnings in recent years, the company’s vaccines business appeared to be on the back foot in the third quarter, brought low by a U.S. market that is currently proving
read more
CGT Catapult annual review shows sector’s impact on economy and patient access More: Advanced therapies boost UK’s life sciences ambitions Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals